The U.S. Food & Drug Administration (FDA) has granted approval for a novel and less invasive belimumab (Benlysta®) treatment for children with systemic lupus erythematosus (SLE) ages five years and ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved a 200 mg Benlysta autoinjector for children aged 5 years and ...

A recent review published in Current Molecular Pharmacology explores the therapeutic potential of melatonin in systemic lupus ...

Detailed mapping of CD4⁺ T cells from children with systemic lupus erythematosus (SLE) has revealed distinct immune cell subsets with likely roles in disease pathogenesis, according to a study led by ...

The US Food and Drug Administration (FDA) has approved the launch of the first clinical trial for chimeric antigen receptor (CAR) T-cell therapy in children with systemic lupus erythematosus. The ...

Seattle Children’s is the first FDA-authorized site to deliver an experimental CAR T-cell therapy to children with lupus, the system said March 11. About 20% of lupus patients have disease onset ...

A previous diagnosis of a mental health disorder may predict neuropsychiatric complications in children with systemic lupus ...

Women with lupus are twice as likely to have a child with autism compared to mothers without the autoimmune disease, new, preliminary research finds. However, the overall risk is still low and the ...